Anti-Staphylococcal enterotoxin B monoclonal antibody (Mapp Biopharmaceutical)

N/A

Report date: 2024/04/19 10:36:04

Base Information

Drug NameAnti-Staphylococcal enterotoxin B monoclonal antibody (Mapp Biopharmaceutical)
Drug Alias NameHU19F1
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMapp Biopharmaceutical Inc
China Registration ClassN/A

Develop Information

Active CompaniesMapp Biopharmaceutical Inc
Inactive CompaniesN/A
Active IndicationsStaphylococcal Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A